Target intelligence / Profile preview

microRNA 548ar (MIR548AR)

Target
MIR548AR
Molecular classification
microRNA, Non-coding RNA, Other
01

Overview

microRNA 548ar (MIR548AR) is a member of the primate-specific miR-548 gene family, encoding a short non-coding RNA molecule that regulates gene expression at the post-transcriptional level[5][8]. Like other microRNAs, miR-548ar binds to specific messenger RNAs (mRNAs), most commonly within the 3' untranslated region, leading to reduced protein translation or mRNA destabilization[4]. The miR-548 family participates in various biological processes and signaling pathways, such as MAPK and Wnt pathways[1][8]. miR-548ar-5p has been identified as a diagnostic or prognostic biomarker in pathology, particularly as a downregulated marker in certain thyroid tumors where its measurement may help distinguish benign from malignant follicular-patterned lesions[1]. Hundreds of potential mRNA targets are predicted for miR-548ar, but the precise disease associations and mechanisms require further experimental confirmation[1][8]. There are no approved drugs known to specifically target this microRNA. - miR-548ar is not a receptor, enzyme, or classical therapeutic target; its main known role is regulatory, as with other microRNAs[4][5][8]. - It is studied primarily as a biomarker rather than a direct target for drug therapy[1]. - There is no evidence of significant safety concerns related to direct targeting or modulation of miR-548ar; its roles in normal physiology and diseases are still being elucidated.

Other names
hsa-mir-548armiR-548armiR-548ar-5p
02

Biological functions

Gene regulationPost-transcriptional gene silencingRegulation of signaling pathways (including MAPK and Wnt)Other
03

Disease associations

CancerOther
04

Biomarkers

miR-548ar-5p expression (for malignancy risk in thyroid nodules)

Beyond the preview

Go deeper on microRNA 548ar (MIR548AR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 548ar (MIR548AR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call